Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Veliparib shows antitumor activity in multiple myeloma

Dec. 10, 2012

RP-3133 significantly inhibits mast cell degranulation in vitro and in vivo

Dec. 10, 2012

Astex Pharmaceuticals presents promising preclinical results for AT-26893

Dec. 10, 2012

Preliminary results of a first-in-human study reveal good safety profile for DENV-1 PIV

Dec. 10, 2012

Results of first-in-human study of NNC-0114-0005 reported

Dec. 10, 2012

Genentech presents phase II results for rontalizumab in patients with SLE

Dec. 10, 2012

REP-9AC in combination with immunostimulatory agents proves effective in HBV-infected patients

Dec. 10, 2012

Preliminary phase I data presented on MLN-0128 for advanced solid malignancies

Dec. 7, 2012

First-in-patient trial data updated for PF-03084014

Dec. 7, 2012

Type I interferon receptor 1 MAb evaluated in patients with scleroderma

Dec. 7, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...